» Articles » PMID: 28180987

Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2017 Feb 10
PMID 28180987
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The diagnosis of malignant diseases worldwide has been determined using F-fluorodeoxyglucose positron emission tomography (FDG-PET). Glucose transporter type 1 (Glut-1) is a key protein associated with the accumulation of FDG in cancer cells. This study evaluated the relationship between Glut-1 expression and FDG accumulation to determine the usefulness of FDG-PET for prediction of long-term outcomes of pancreatic cancer.

Methods: The expression of Glut-1 was immunohistochemically examined in 138 surgically resected pancreatic cancer specimens. The Glut-1-positive and Glut-1-negative groups were analyzed with respect to their clinicopathologic characteristics and prognosis. Before surgery, 93 patients underwent FDG-PET and measurement of the corrected maximum standardized uptake value (cSUVmax). The relationship between Glut-1 expression and cSUVmax were examined, and prognostic factors were identified using uni- and multivariate analyses.

Results: Glut-1 was positive in 69 patients (50%). The median relapse-free and overall survival times were significantly shorter in the Glut-1-positive group (11 vs. 22 months, respectively) than in the Glut-1-negative group (23 vs. 42 months, respectively). The cSUVmax was significantly associated with long-term survival. The relapse-free and overall survival rates were significantly poorer in the high-cSUVmax group than in the low-cSUVmax group. Glut-1 expression was associated with cSUVmax accumulation. In the multivariate Cox regression analysis using forward stepwise selection, male gender, positive lymph node metastases, high CA19-9, and high cSUVmax were identified as independent prognostic factors for pancreatic cancer.

Conclusion: A significant relationship exists between high preoperative cSUVmax and Glut-1 expression. High cSUVmax is one of the prognostic factors for overall survival after resection of pancreatic cancer.

Citing Articles

Comparison of multiple machine learning models for predicting prognosis of pancreatic ductal adenocarcinoma based on contrast-enhanced CT radiomics and clinical features.

Huang Y, Zhang H, Ding Q, Chen D, Zhang X, Weng S Front Oncol. 2024; 14:1419297.

PMID: 39605884 PMC: 11598923. DOI: 10.3389/fonc.2024.1419297.


Prognostic value of preoperative [ Ga]Ga-FAPI-04 PET/CT in patients with resectable pancreatic ductal adenocarcinoma in correlation with immunohistological characteristics.

Ding J, Qiu J, Hao Z, Huang H, Liu Q, Liu W Eur J Nucl Med Mol Imaging. 2023; 50(6):1780-1791.

PMID: 36695823 DOI: 10.1007/s00259-022-06100-4.


Biological and Clinical Impacts of Glucose Metabolism in Pancreatic Ductal Adenocarcinoma.

Liu Z, Hayashi H, Matsumura K, Uemura N, Shiraishi Y, Sato H Cancers (Basel). 2023; 15(2).

PMID: 36672448 PMC: 9856866. DOI: 10.3390/cancers15020498.


Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP/TAZ-Hedgehog signalling axis in pancreatic cancer.

Liu Z, Hayashi H, Matsumura K, Ogata Y, Sato H, Shiraishi Y Br J Cancer. 2022; 128(5):844-856.

PMID: 36536047 PMC: 9977781. DOI: 10.1038/s41416-022-02106-9.


Prognostic value of glycolysis markers in pancreatic cancer: A systematic review and meta-analysis.

Wang C, Xu R, Song J, Chen Y, Yin X, Ruze R Front Oncol. 2022; 12:1004850.

PMID: 36172154 PMC: 9510923. DOI: 10.3389/fonc.2022.1004850.